You are here: Home » 2025 » November » Archives for 27th

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Mont–Saint–Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, Dec. 4, 2025. The fireside chat is scheduled at 1:30 p.m. (ET) the same day via webcast.

A live audio webcast of the presentation will be available online at the investor relations page of the Company’s website at investors.nyxoah.com.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio system, a patient–centered, leadless and battery–free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study and receipt of approval from the FDA for a subset of adult patients with moderate to severe OSA with an AHI of greater than or equal to 15 and less than or equal to 65.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. FDA approved in August 2025 as prescription–only device.

Contact:

Nyxoah
John Landry
Chief Financial Officer
[email protected]

Rémi Renard
Chief Investor Relations & Corporate Communication Officer
[email protected]

Attachment


GLOBENEWSWIRE (Distribution ID 1001141443)

Nyxoah Participera à la Piper Sandler 37th Annual Healthcare Conference

Nyxoah Participera à la Piper Sandler 37th Annual Healthcare Conference

Mont–Saint–Guibert, Belgique – 27 novembre 2025, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société ») une société de technologie médicale spécialisée dans le développement et la commercialisation de solutions innovantes pour le traitement de l'Apnée Obstructive du Sommeil (« AOS ») par neuromodulation, a annoncé aujourd'hui que son management participera à une discussion informelle lors de la Piper Sandler 37th Annual Healthcare Conference, le jeudi 4 décembre 2025. La discussion informelle est prévue à 13h30 ET le même jour et sera diffusée en webcast.

Une webdiffusion audio en direct de la présentation sera disponible en ligne sur la page Relations avec les investisseurs du site web de la Société à l'adresse investors.nyxoah.com.

À propos de Nyxoah
Nyxoah opère dans le secteur des technologies médicales. Elle se concentre sur le développement et la commercialisation de solutions innovantes destinées à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS). La principale solution de Nyxoah est le système Genio®, une thérapie de neurostimulation du nerf hypoglosse sans sonde et sans batterie qui a reçu le marquage CE, centrée sur le patient et destinée à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS), le trouble respiratoire du sommeil le plus courant au monde. Ce dernier est associé à un risque accru de mortalité et des comorbidités, dont les maladies cardiovasculaires. La visions de Nyxoah est que les patients souffrant de SAOS doivent pouvoir profiter de nuits réparatrices et vivre pleinement leur vie.

À la suite de la finalisation probante de l’étude BLAST OSA, le système Genio® a reçu le marquage européen CE en 2019. Nyxoah a réalisé avec succès deux IPO : l’une sur Euronext Bruxelles en septembre 2020 et l’autre sur le NASDAQ en juillet 2021. Grâce aux résultats positifs de l'étude BETTER SLEEP, Nyxoah a reçu le marquage CE pour l’extension de ses indications thérapeutiques aux patients souffrant de collapsus concentrique complet (CCC), pour lesquels les thérapies concurrentes sont actuellement contre–indiquées. En outre, la Société a annoncé les résultats positifs de l'étude pivot DREAM IDE et l'obtention de l'autorisation de la FDA pour un sous–groupe de patients adultes atteints d'AOS modérée à sévère avec un IAH supérieur ou égal à 15 et inférieur ou égal à 65.

Pour plus d’informations, visitez www.nyxoah.com

Attention – marquage CE depuis 2019. Approuvé par la FDA en août 2025 en tant que dispositif disponible uniquement sur prescription médicale.

Contacts :

Nyxoah
John Landry, CFO
[email protected]

Rémi Renard
Chief Investor Relations & Corporate Communication Officer
[email protected]

Pièce jointe


GLOBENEWSWIRE (Distribution ID 1001141443)

ROSEN, A LEADING LAW FIRM, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LRN

NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Stride securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Stride class action, go to https://rosenlegal.com/submit–form/?case_id=30689 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 12, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made misleading statements and omissions regarding Stride’s products and services to public and private schools, school district, and charter boards. Throughout the Class Period, Stride represented to investors that “[t]hese products and services, spanning curriculum, systems, instruction, and support services are designed to help learners of all ages reach their full potential through inspired teaching and personalized learning.” Unbeknownst to investors, Stride was inflating enrollment numbers, cutting staff costs beyond required statutory limits, ignoring compliance requirements, and losing existing and potential enrollments. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Stride class action, go to https://rosenlegal.com/submit–form/?case_id=30689 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
[email protected]
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9593174)

ROSEN, A LEADING LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Skye securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Skye Bioscience, Inc. class action, go to https://rosenlegal.com/submit–form/?case_id=48064 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements regarding Skye’s business, operations, and prospects. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) nimacimab was less effective than defendants had led investors to believe; (2) accordingly, nimacimab’s clinical, regulatory, and commercial prospects were overstated; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Skye Bioscience class action, go to https://rosenlegal.com/submit–form/?case_id=48064 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686–1060
        Toll Free: (866) 767–3653
        Fax: (212) 202–3827
        [email protected]
        www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9593176)

Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP) resulting from allegations that Zions Bancorporation may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Zions Bancorporation, N.A. securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit–form/?case_id=46354 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: On October 15, 2025, Zions Bancorporation, N.A. announced that it would be taking a $50 million charge–off for a loan underwritten by its wholly–owned subsidiary, California Bank & Trust, in light of “apparent misrepresentations and contractual defaults by the Borrowers and Obligors and other irregularities with respect to the Loans and collateral.” Zions Bancorporation, N.A. further disclosed that it would be engaging counsel to coordinate an independent review of the matter.

On this news, Zions Bancorporation, N.A. common stock fell 13.14% on October 16, 2025.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
[email protected]
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9593185)

FLY Investor News: If You Have Suffered Losses in Firefly Aerospace Inc. (NASDAQ: FLY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Firefly Aerospace Inc. (NASDAQ: FLY) resulting from allegations that Firefly Aerospace may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Firefly Aerospace securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit–form/?case_id=46681 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: On September 22, 2025, after market close, The Wall Street Journal published an article entitled “Firefly Aerospace Posts Wider Loss as Revenue Falls.” The article stated that Firefly “logged a wider loss and lower revenue in its latest quarter, marking its first earnings report since its stock market debut last month.”

On this news, Firefly stock fell 15.3% on September 23, 2025.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
[email protected]
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9593175)

Bitget lança a Fase 7 do Stock Futures Rush com US$ 280.000 em ações tokenizadas da Tesla (TSLA) disponíveis para compra

VICTORIA, Seychelles, Nov. 27, 2025 (GLOBE NEWSWIRE) — A Bitget, maior Corretora Universal (UEX) do mundo, anunciou hoje a Fase 7 do Stock Futures Rush, uma nova campanha de trading que oferece aos usuários a chance de ganhar uma parte de US$ 280.000 em ações tokenizadas equivalentes da Tesla (TSLA), com um prêmio individual máximo de US$ 8.000 em TSLA. A promoção estará ativa de 24 de novembro, às 21h30 (UTC+8), até 29 de novembro, às 4h (UTC+8).

A Fase 7 apresenta três linhas de atividade distintas. Em primeiro lugar, a promoção Mystery Box garante que todos os usuários participantes que completarem até três tarefas diárias receberão uma recompensa enquanto os estoques durarem. Na segunda atividade, os traders ganham créditos ao atingirem metas diárias de volume de futuros, o que lhes dá a oportunidade de receber uma parte dos US$ 80.000 em ações TSLA. O limite de qualificação será anunciado um dia após o término da promoção.

Por fim, o desafio do ranking concede o maior prêmio —de US$ 8.000 em TSLA — a um único vencedor, além de recompensas escalonadas, no total de US$ 150.000 em TSLA, para os usuários com o maior volume de compras de contratos futuros durante a promoção. Os pares de futuros elegíveis incluem TSLAUSDT, AAPLUSDT, NVDAUSDT, MSTRUSDT, GOOGLUSDT, CRCLUSDT, COINUSDT, MSFTUSDT, AMZNUSDT, QQQUSDT e METAUSDT. As operações realizadas via API e as negociações regulares serão consideradas na avaliação de elegibilidade, porém as subcontas institucionais e as PRO estão excluídas.

Ao combinar a exposição tradicional a ações com a flexibilidade nativa das criptomoedas, a Bitget continua a expandir o acesso aos mercados globais por meio do seu modelo UEX, tornando ferramentas e oportunidades avançadas acessíveis a uma ampla variedade de investidores.

Para consultar o conjunto completo de regras da campanha e atualizações em tempo real, acesse aqui.

Sobre a Bitget

Fundada em 2018, a Bitget é a maior Corretora Universal (UEX) do mundo, atendendo mais de 120 milhões de usuários com acesso a milhões de tokens criptográficos, ações tokenizadas, ETFs e outros ativos do mundo real, oferecendo acesso em tempo real ao preço do Bitcoin, Ethereum, XRP e a outros preços de criptomoedas, tudo em uma única plataforma. O ecossistema se compromete a ajudar os usuários a negociar de forma mais inteligente, com suas ferramentas de negociação impulsionadas por IA, interoperabilidade entre tokens em Bitcoin, Ethereum, Solana e BNB Chain, além de maior acesso a ativos do mundo real. No lado descentralizado, o Bitget Wallet é um aplicativo de finanças do dia a dia, criado para tornar as criptomoedas simples, seguras e parte da sua rotina financeira. Atendendo a mais de 80 milhões de usuários, ela conecta os trilhos da blockchain às finanças do mundo real, oferecendo uma plataforma tudo–em–um para entrada e saída de capital, negociação, ganhos e pagamentos, de forma ininterrupta.

A Bitget está impulsionando a adoção de criptomoedas por meio de parcerias estratégicas, como seu papel de parceira oficial de criptomoedas da principal liga de futebol do mundo, LALIGA, nos mercados do ORIENTE, SUDESTE ASIÁTICO e AMÉRICA LATINA. Alinhada à sua estratégia de impacto global, a Bitget se uniu ao UNICEF para apoiar a educação em blockchain de 1,1 milhão de pessoas até 2027. No mundo do automobilismo, a Bitget é a corretora de criptomoedas parceira exclusiva do MotoGP™, um dos campeonatos mais emocionantes do mundo.

Para mais informações, acesse: Site | Twitter | Telegram | LinkedIn | Discord | Bitget Wallet

Para comunicação social, envie um e–mail para: [email protected] 

Aviso de risco: os preços dos ativos digitais estão sujeitos a flutuações e podem apresentar volatilidade significativa. Os investidores são aconselhados a alocar apenas os fundos que possam correr o risco de perder. O valor de qualquer investimento pode ser impactado, e há a possibilidade de que os objetivos financeiros não sejam alcançados e que nem o capital investido seja recuperado. Deve–se sempre buscar aconselhamento financeiro independente, além de considerar cuidadosamente a experiência financeira pessoal e a situação individual. O desempenho passado não é um indicador confiável de resultados futuros. A Bitget não se responsabiliza por eventuais perdas incorridas. O conteúdo deste documento não deve ser interpretado como aconselhamento financeiro. Para mais informações, consulte os nossos Termos de Uso.

Uma foto que acompanha este anúncio está disponível em http://www.globenewswire.com/NewsRoom/AttachmentNg/d9a3d62e–744d–40b3–8ff1–cbfa4b6b1db7


GLOBENEWSWIRE (Distribution ID 1001141447)

Bitget lance la phase 7 de Stock Futures Rush avec 280 000 dollars d’actions tokenisées TSLA à gagner

VICTORIA, Seychelles, 27 nov. 2025 (GLOBE NEWSWIRE) — Bitget, la plus grande bourse universelle (UEX) au monde, a annoncé aujourd’hui le lancement de la phase 7 de Stock Futures Rush, une nouvelle campagne de trading offrant aux utilisateurs la possibilité de remporter une part de 280 000 $ en actions TSLA tokenisées, avec un prix individuel maximum de 8 000 $ TSLA. La promotion se déroulera du 24 novembre à 21 h 30 (UTC+8) au 29 novembre à 4 h 00 (UTC+8).

La phase 7 propose trois types d’activités distincts. Tout d’abord, le concours Mystery Box garantit à chaque utilisateur participant qui accomplit jusqu’à trois tâches quotidiennes de recevoir une récompense, dans la limite des stocks disponibles. La deuxième activité permet aux traders de gagner des crédits en atteignant des paliers quotidiens de volume sur les contrats à terme, leur donnant la possibilité de recevoir une part de 80 000 $ TSLA. Le seuil de qualification sera annoncé un jour après la fin de la promotion.

Enfin, le challenge du classement attribue le plus gros prix, 8 000 $ TSLA, à un seul gagnant, en plus de récompenses par paliers issues d’une cagnotte de 150 000 $ TSLA pour les utilisateurs ayant le plus grand volume d’achat de contrats à terme pendant la promotion. Les paires de contrats à terme éligibles comprennent TSLAUSDT, AAPLUSDT, NVDAUSDT, MSTRUSDT, GOOGLUSDT, CRCLUSDT, COINUSDT, MSFTUSDT, AMZNUSDT, QQQUSDT et METAUSDT. Le trading via API ou manuel est pris en compte, cependant les comptes institutionnels et les sous–comptes PRO sont exclus.

En combinant l’exposition aux actions traditionnelles avec la flexibilité propre aux cryptomonnaies, Bitget continue d’élargir l’accès aux marchés mondiaux via son modèle UEX, rendant des outils et opportunités avancés accessibles à un large panel de traders.

Pour consulter l’ensemble des règles de la campagne et les mises à jour en temps réel, cliquez ici.

À propos de Bitget

Fondée en 2018, Bitget est la plus grande bourse universelle (UEX) au monde, servant plus de 120 millions d’utilisateurs et donnant accès à des millions de jetons crypto, actions tokenisées, ETF et autres actifs du monde réel, tout en fournissant en temps réel les prix du Bitcoin, d’Ethereum, de XRP et d’autres cryptomonnaies, au sein d’une seule et même plateforme. L’écosystème vise à aider les utilisateurs à trader plus intelligemment grâce à ses outils de trading alimentés par l’IA, l’interopérabilité entre jetons sur Bitcoin, Ethereum, Solana et BNB Chain, et entend étendre l’accès des utilisateurs aux actifs réels. Au regard de la finance décentralisée, Bitget Wallet est une application financière conçue pour simplifier et sécuriser la crypto, et l’intégrer à la finance de tous les jours. Forte de ses plus de 80 millions d’utilisateurs, elle relie les infrastructures blockchain au monde réel sous la forme d’une plateforme tout–en–un conçue pour acheter et vendre, échanger, dégager des revenus et payer en toute fluidité.

Bitget entend faire adopter les cryptomonnaies grâce à des partenariats stratégiques, comme en témoigne son rôle de partenaire crypto officiel de la meilleure ligue de football au monde, LALIGA, sur les marchés de l’Est, de l’Asie du Sud–Est et de l’Amérique latine. Pour faire écho à sa stratégie d’impact mondial, Bitget s’est associée à l’UNICEF pour soutenir l’éducation à la blockchain auprès de 1,1 million de personnes d’ici à 2027. Dans l’univers des sports mécaniques, Bitget est le partenaire officiel crypto exclusif du MotoGP™, l’un des championnats les plus passionnants du monde.

Pour en savoir plus, veuillez consulter : Site Internet | Twitter | Telegram | LinkedIn | Discord | Bitget Wallet

Pour toute demande de renseignements des médias, veuillez nous contacter à l’adresse suivante : [email protected] 

Mise en garde sur les risques : les cours des actifs numériques peuvent fluctuer et connaître une forte volatilité. Il est recommandé aux investisseurs d’investir uniquement la somme qu’ils peuvent se permettre de perdre. La valeur de vos investissements peut être affectée et il est possible que vous n’atteigniez pas vos objectifs financiers ou que vous ne parveniez pas à récupérer votre capital. Nous vous encourageons à toujours solliciter les conseils d’un spécialiste financier indépendant et à tenir compte de votre expérience et de votre situation financière. Les performances passées ne constituent pas un indicateur fiable des résultats futurs. Bitget décline toute responsabilité quant à toute perte potentielle encourue. Nulle disposition des présentes ne saurait être interprétée comme un conseil d’ordre financier. Pour tout complément d’information, veuillez consulter nos Conditions d’utilisation.

Une photo annexée au présent communiqué est disponible à l’adresse suivante : http://www.globenewswire.com/NewsRoom/AttachmentNg/d9a3d62e–744d–40b3–8ff1–cbfa4b6b1db7


GLOBENEWSWIRE (Distribution ID 1001141447)

‘Mais Que’ – Axi lança nova campanha com estrelas do Manchester City

SYDNEY, Nov. 27, 2025 (GLOBE NEWSWIRE) — A Axi, líder financeira em negociação on–line de CFD e FX, revelou sua mais recente campanha – Mais Que, apresentando as estrelas do Manchester City, Nathan Aké, Oscar Bobb e Omar Marmoush.

Hannah Hill, Chefe de Marca e Patrocínio na Axi, compartilhou seu entusiasmo pela nova campanha da corretora, dizendo: “Desde a parceria com o Man City em 2020, estes anos têm sido nada menos que extraordinários, tanto para o clube quanto para a Axi. O Man City é mais que um clube de futebol, e a Axi é mais que uma corretora. Ambos somos movidos por mais que o sucesso; somos impulsionados pela ambição, inovação e paixão. Ser ‘Mais Que’ é o nosso modo de vida e nossa nova campanha traz isso à tona.”

Como parceira oficial de negociação on–line do Manchester City, a Axi criou conteúdo envolvente ao longo dos anos para apresentar sua marca. Na temporada passada, a campanha ‘Quatro Anos’ da corretora celebrou seus quatro anos de colaboração com o clube, refletindo sobre suas conquistas e alcançando novos patamares juntos.

Além da parceria com o Manchester City, a Axi também é a parceira oficial de negociação on–line LATAM do clube da LaLiga, Girona FC, e a parceira oficial de negociação on–line do clube brasileiro, Esporte Clube Bahia. Em 2023, a Axi também nomeou o jogador da seleção inglesa John Stones como seu Embaixador da Marca – uma colaboração que foi recentemente renovada, reafirmando o compromisso da corretora com a inovação, excelência e o mundo do futebol.

Assista ao vídeo aqui: https://youtu.be/m91D37TrDOg

Sobre a Axi

A Axi é uma empresa global de trading on–line de FX e CFD, com milhares de clientes em mais de 100 países. A Axi oferece CFDs para várias classes de ativos, incluindo forex, ações, ouro, petróleo, café e muito mais.

Para mais informações ou comentários adicionais da Axi, entre em contato: [email protected]

Saiba mais sobre a Axi aqui: http://www.axi.com

Sobre o Manchester City Football Club:  

O Manchester City FC foi inicialmente fundado em 1880 como St Mark’s West Gorton e tornou–se oficialmente Manchester City FC em 1894. Situado no complexo mais amplo do Etihad Campus, a área do Clube inclui o Etihad Stadium com capacidade para 53.500 pessoas, o Joie Stadium com capacidade para 7.000 pessoas e a City Football Academy, uma instalação de última geração para desempenho, treinamento e desenvolvimento de jovens, que abriga as equipes masculina, feminina e de base do Clube.  

Classificado como o clube de futebol com a marca mais valiosa da Premier League pela Brand Finance, o Manchester City FC está atualmente desenvolvendo uma experiência de torcedor de primeira classe e um destino de entretenimento e lazer durante todo o ano no Etihad Campus. O Clube está comprometido em operar de maneira sustentável e socialmente responsável e garante que a igualdade, diversidade e inclusão estejam incorporadas em seus processos de tomada de decisão, cultura e práticas. 

Promovido pela AxiTrader LLC. Os derivativos OTC apresentam um elevado risco de perda de investimento. Este conteúdo pode não estar disponível em sua região.

Uma foto que acompanha este anúncio está disponível em http://www.globenewswire.com/NewsRoom/AttachmentNg/ae46b728–6a12–4c0e–8984–c69005d32eef/pt 


GLOBENEWSWIRE (Distribution ID 1001141433)

„More Than“ – Axi startet neue Kampagne mit Stars von Manchester City

SYDNEY, Nov. 27, 2025 (GLOBE NEWSWIRE) — Axi, ein führendes Finanzunternehmen im Bereich Online–CFD– und Devisenhandel, hat seine neueste Kampagne „More Than” vorgestellt – mit den Manchester–City–Stars Nathan Aké, Oscar Bobb und Omar Marmoush.

Hannah Hill, Head of Brand and Sponsorship bei Axi, zeigt sich begeistert von der neuen Broker–Kampagne: „Im Jahr 2020 haben wir unsere Partnerschaft mit Man City begonnen. Die folgenden Jahre waren für den Verein und für Axi gleichermaßen außergewöhnlich erfolgreich. Manchester City ist mehr als nur ein Fußballverein – und Axi mehr als nur ein Broker.“ Uns beide motiviert mehr als nur Erfolg – wir werden von Ehrgeiz, Innovationskraft und Leidenschaft getragen. ‚Being more than‘ ist unser Leitmotiv – und genau das bringt unsere neue Kampagne zum Ausdruck.“

Als offizieller Online–Trading–Partner von Manchester City hat Axi über die Jahre hinweg starke Inhalte entwickelt, um die Marke wirkungsvoll zu präsentieren. In der vergangenen Saison feierte die „Four Years“–Kampagne des Brokers die vierjährige Zusammenarbeit mit dem Club, blickte auf gemeinsame Erfolge zurück und markierte zugleich neue gemeinsame Meilensteine.

Zusätzlich zur Partnerschaft mit Manchester City ist Axi auch offizieller LATAM Online–Trading–Partner des LaLiga–Clubs Girona FC sowie offizieller Online–Trading–Partner des brasilianischen Clubs Esporte Clube Bahia. IIm Jahr 2023 ernannte Axi zudem den englischen Nationalspieler John Stones zu seinem Markenbotschafter – eine Partnerschaft, die kürzlich verlängert wurde und das Engagement des Brokers für Innovation, Exzellenz und den Fußballsport unterstreicht.

Sehen Sie sich das Video hier an: https://youtu.be/tnMCx92MaZA

Über Axi

Axi ist ein globales Online–Devisen– und CFD–Handelsunternehmen mit Tausenden von Kundinnen und Kunden in über 100 Ländern der Welt. Axi bietet CFDs für verschiedene Anlageklassen an, darunter Devisen, Aktien, Gold, Öl, Kaffee und mehr.

Für weitere Informationen oder zusätzliche Statements von Axi wenden Sie sich bitte an: [email protected]

Erfahren Sie hier mehr über Axi: http://www.axi.com

Über den Manchester City Football Club:  

Der Manchester City FC wurde ursprünglich 1880 als St. Mark's West Gorton gegründet und 1894 offiziell in Manchester City FC umbenannt. Der Club ist auf dem weitläufigen Etihad Campus beheimatet, zu dem das Etihad Stadium mit einer Kapazität von 53.500 Zuschauerinnen und Zuschauer, das Joie Stadium mit 7.000 Plätzen sowie die City Football Academy gehören – eine hochmoderne Leistungs–, Trainings– und Nachwuchseinrichtung, in der die Herren–, Frauen– und Akademiemannschaften des Vereins trainieren und spielen.   

Manchester City – laut Brand Finance die wertvollste Marke der Premier League – baut den Etihad Campus derzeit weiter aus und entwickelt ihn zu einem Top–Ziel für Fans sowie für Entertainment– und Freizeitangebote das ganze Jahr über. Der Verein fühlt sich nachhaltigem und sozial verantwortlichem Handeln verpflichtet und stellt sicher, dass Gleichberechtigung, Vielfalt und Inklusion fest in Entscheidungsprozessen, Kultur und täglichen Abläufen verankert sind. 

Beworben von AxiTrader LLC. OTC–Derivate bergen ein hohes Verlustrisiko für die Anlegerinnen und Anleger. Dieser Inhalt ist in Ihrer Region möglicherweise nicht verfügbar.

Ein Foto zu dieser Mitteilung finden Sie unter http://www.globenewswire.com/NewsRoom/AttachmentNg/ae46b728–6a12–4c0e–8984–c69005d32eef/de


GLOBENEWSWIRE (Distribution ID 1001141433)